Anti-Ro/SS-A and anti-La/SS-B autoantibodies were detected in 30% and 15% of ACA+/SS patients, compared to 70.5% (P = 0.003) and 41% (P = 0.056) of ACA-/SS patients, respectively. The gene discussed is CALR; the disease is synovial sarcoma.